Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients

In spite of the effective implementation of screening programs, uterine cervical carcinoma (UCC) remains one of the major causes of cancer death among women around the world. The aim of this study was to investigate the prognostic value of serum human epididymis protein 4 (HE4) in UCC. Pre-treatment...

Full description

Bibliographic Details
Main Authors: Eliana Bignotti, Laura Zanotti, Paola Todeschini, Valentina Zizioli, Chiara Romani, Davide Capoferri, Germana Tognon, Enrico Sartori, Stefano Calza, Franco Odicino, Antonella Ravaggi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
uterine cervical carcinoma
HE4
biomarker
prognosis
serum
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.584022/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.584022/full

Similar Items